Cuker A - Search Results

1

Dynamic antibody-binding properties in the pathogenesis of HIT.

Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW, Cines DB. Sachais BS, et al. Among authors: cuker a. Blood. 2012 Aug 2;120(5):1137-42. doi: 10.1182/blood-2012-01-407262. Epub 2012 May 10. Blood. 2012. PMID: 22577175 Free PMC article.

2

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time.

Cuker A, Ptashkin B, Konkle BA, Pipe SW, Whinna HC, Zheng XL, Cines DB, Pollak ES. Cuker A, et al. J Thromb Haemost. 2009 Jan;7(1):80-6. doi: 10.1111/j.1538-7836.2008.03224.x. Epub 2008 Nov 11. J Thromb Haemost. 2009. PMID: 19017257 Free article.

3

Romiplostim: chronic therapy for a chronic disease?

Cuker A, Abrams CS. Cuker A, et al. Blood. 2009 Mar 5;113(10):2122-3. doi: 10.1182/blood-2008-12-191486. Blood. 2009. PMID: 19264923 Free article. No abstract available.

4

Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopenia.

Cuker A, Chiang EY, Cines DB. Cuker A, et al. Curr Drug Saf. 2010 Apr;5(2):171-81. doi: 10.2174/157488610790936196. Curr Drug Saf. 2010. PMID: 19534637 Review.

5

ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?

Cuker A, Ortel TL. Cuker A, et al. Hematology Am Soc Hematol Educ Program. 2009:250-2. doi: 10.1182/asheducation-2009.1.250. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008206 Review.

6

The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.

Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. Cuker A, et al. J Thromb Haemost. 2010 Dec;8(12):2642-50. doi: 10.1111/j.1538-7836.2010.04059.x. J Thromb Haemost. 2010. PMID: 20854372 Free article.

7

Immune thrombocytopenia.

Cuker A, Cines DB. Cuker A, et al. Hematology Am Soc Hematol Educ Program. 2010;2010:377-84. doi: 10.1182/asheducation-2010.1.377. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239822 Review.

8

Evidence-based mini-review: Is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?

Cuker A, Cines DB. Cuker A, et al. Hematology Am Soc Hematol Educ Program. 2010;2010:385-6. doi: 10.1182/asheducation-2010.1.385. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239823 Review.

9

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.

Cuker A, Coles AJ, Sullivan H, Fox E, Goldberg M, Oyuela P, Purvis A, Beardsley DS, Margolin DH. Cuker A, et al. Blood. 2011 Dec 8;118(24):6299-305. doi: 10.1182/blood-2011-08-371138. Epub 2011 Sep 29. Blood. 2011. PMID: 21960587 Free article. Clinical Trial.

10

False normal von Willebrand factor activity by monoclonal antibody-based ELISA in a patient with type 2A(IID) von Willebrand disease.

Ahmad S, Ptashkin B, DiGiovanni C, Cines DB, Konkle BA, Cuker A. Ahmad S, et al. Among authors: cuker a. Thromb Haemost. 2011 Dec;106(6):1224-5. doi: 10.1160/TH11-07-0484. Epub 2011 Oct 6. Thromb Haemost. 2011. PMID: 21979291 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters